As Dr. Vinay Prasad takes over the very important Center for Biologics Evaluation & Research at ...
With yet another exciting Press Release this week, AstraZeneca announced that the DESTINY-Breast09 t...
In a powerful video discussion with Dr. Biagio Ricciuti, Dana-Farber Cancer Center, Dr. Marcelo Cora...
As part of our competitive intelligence research, we were comparing KOL Pulse to other platforms in ...
The recent approval of Blenrep (belantamab mafodotin) in the UK for the treatment of relapsed/refrac...
The Role of Memes in Communicating Lung Cancer Treatment Challenges: A Focus on EGFR Mutation Therap...
Top KOL Influencers of the DeLLphi-304 Trial Discussions Doctor Name Profile Image Tweet Content Sou...
Insights from the Oncology Brothers Podcast: Dual Checkpoint Inhibition in MSI-High Colorectal Cance...
